Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,552 | 31,999 | 104,642 | 79,515 | 58,106 |
| Marketable Securities | 64,126 | 85,189 | 78,238 | 79,576 | 24,757 |
| Receivables | 12,610 | 21,513 | 20,654 | 47,272 | 26,544 |
| Inventories | 8,608 | 17,408 | 20,414 | 41,715 | 34,781 |
| TOTAL | $126,292 | $175,942 | $229,643 | $252,051 | $146,431 |
| Non-Current Assets | |||||
| PPE Net | 52,086 | 55,174 | 43,172 | 38,382 | 29,872 |
| Investments And Advances | 8,446 | 46,733 | 53,796 | 43,219 | 23,262 |
| Other Non-Current Assets | 5,703 | 1,231 | 29,525 | 17,633 | 15,556 |
| TOTAL | $66,235 | $103,138 | $126,493 | $99,234 | $68,690 |
| Total Assets | $192,527 | $279,080 | $356,136 | $351,285 | $215,121 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50,859 | 30,438 | 27,359 | 35,611 | 27,454 |
| Accrued Expenses | 56,001 | 175,632 | 51,255 | 54,825 | 18,222 |
| TOTAL | $106,860 | $207,179 | $78,614 | $90,436 | $45,676 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 1,109 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 128,767 | 5,692 | 7,933 | 8,544 | 3,778 |
| TOTAL | $128,767 | $5,692 | $7,933 | $8,544 | $3,778 |
| Total Liabilities | $235,627 | $212,871 | $86,547 | $98,980 | $49,454 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,428 | 73,764 | 71,957 | 71,510 | 70,919 |
| Common Shares | 744 | 736 | 719 | 719 | 707 |
| Retained earnings | -336,083 | -212,424 | 12,664 | 5,074 | -51,056 |
| Other shareholders' equity | -269 | -459 | -323 | -173 | -45 |
| TOTAL | $-43,100 | $66,209 | $269,589 | $252,305 | $165,667 |
| Total Liabilities And Equity | $192,527 | $279,080 | $356,136 | $351,285 | $215,121 |